Smaller, faster trials can improve cancer patient survival
Sunday, September 25, 2011 - 20:30
in Health & Medicine
Gains in cancer survival over the long term could be improved by running smaller, faster trials with less stringent evidence criteria, research suggests. The introduction of targeted treatments and the increased knowledge of tumor biology has meant that common cancers are more frequently recognized as consisting of small subsets with particular abnormalities. These could be targeted by specific therapies, tested by smaller trials.